Archive for 'Biopharmacy'

100th spin-off of the University of Liège, SYNOLYNE SA (Liège, Belgium), develops patented chitosan-based hydrogel to wipe out arthritis.

100th spin-off of the University of Liège, SYNOLYNE SA (Liège, Belgium), develops patented chitosan-based hydrogel to wipe out arthritis.

SYNOLYNE SA, the new spin-off of Liège University and spin-out of Kitozyme SA, is specialized in the research, development and marketing of a chitosan-based hydrogel with mechanical and biological properties designed to protect the cartilage and [...]

Delphi Genetics (Gosselies, Belgium) closes a deal granting Merck –MSD broad-based licensing for the use of the StabyExpress™ system.

Delphi Genetics (Gosselies, Belgium) closes a deal granting Merck –MSD broad-based licensing for the use of the StabyExpress™ system.

Delphi Genetics SA (“Delphi”) has recently sealed a deal with MSD, a subsidiary of Merck & Co (New Jersey, USA) granting a broad-based licensing agreement for the use of the StabyExpress™ technology. The innovative technology offers [...]

Janssen Pharmaceutica expanding in Wallonia (La Louvière, Belgium) with opening of new European center dedicated to pharmaceutical drugs distribution.

Janssen Pharmaceutica expanding in Wallonia (La Louvière, Belgium) with opening of new European center dedicated to pharmaceutical drugs distribution.

Janssen Pharmaceutica is broadening its presence in Wallonia with the opening of a new European center dedicated to the distribution of pharmaceutical products. A company specializing in a wide range of areas, such as neurosciences, oncology [...]

UCB reinforcing its biotech activity with new bio pilot center in Braine-L’Alleud (Belgium)

UCB reinforcing its biotech activity with new bio pilot center in Braine-L’Alleud (Belgium)

With the opening of its new pilot biotechnology center, UCB is gearing up to reinforce its biotech activity through industry-academia research and collaboration. As one of the first plants of its kind in Belgium to produce [...]

iSTAR Medical (Isnes, Belgium) has insight for eyesight with the development of an innovative ophthalmic implant to treat Glaucoma.

iSTAR Medical (Isnes, Belgium) has insight for eyesight with the development of an innovative ophthalmic implant to treat Glaucoma.

Another wonderful story has unfolded in Belgium with the creation of iSTAR Medical SA (Isnes, Belgium), a subsidiary of Healionics Corporation (Seattle, USA), a company specializing in the development and manufacturing of STAR® Biomaterials for implanted [...]

International Drug Development Institute (IDDI, Louvain-La-Neuve, Belgium) to develop an innovative Central Statistical Monitoring (CSM) service.

International Drug Development Institute (IDDI, Louvain-La-Neuve, Belgium) to develop an innovative Central Statistical Monitoring (CSM) service.

Active in Europe, the United States and Asia, a company respectfully established in the fields of biostatistics, data management and central randomization, IDDI has created a new monitoring system responding to the importance and high recommendation of [...]

UCB and Amgen Initiate Sclerostin Antibody Phase 3 program in patients with postmenopausal osteoporosis

UCB and Amgen Initiate Sclerostin Antibody Phase 3 program in patients with postmenopausal osteoporosis

First Patient Randomized Marks Start of Phase 3 Program to Evaluate Safety and Efficacy of CDP7851/AMG 785 in Women With Postmenopausal Osteoporosis Brussels, Belgium & Thousand Oaks, Calif., (April 4, 2012) UCB (Euronext Brussels: UCB) and [...]

Prestigious international stem cell award (ISSCR) is granted to Belgian Dr. Cédric Blanpain (FNRS-ULB/WELBIO).

Prestigious international stem cell award (ISSCR) is granted to Belgian Dr. Cédric Blanpain (FNRS-ULB/WELBIO).

The ISSCR (International Society of Stem Cell Research), an organization bringing together top specialists worldwide, has named Dr. Cédric Blanpain as the recipient of the fourth annual ISSCR-University of Pittsburgh Outstanding Young Investigator Award. For the first time, [...]

Arlenda S.A. takes a step outside Europe announcing Arlenda Inc. as their U.S. subsidiary.

Arlenda S.A. takes a step outside Europe announcing Arlenda Inc. as their U.S. subsidiary.

In the hotly competitive pharmaceutical sector, Arlenda SA(Spin-off – University of Liège, Belgium) is challenging their ability to create a space for themselves on the US market. In November 2011, Bruno Boulanger (CEO, Arlenda SA), and [...]

iTeos Therapeutics (Gosselies, Belgium), kicks-off to develop innovative immunotherapy compounds in an effort to cure certain cancers.

iTeos Therapeutics (Gosselies, Belgium), kicks-off to develop innovative immunotherapy compounds in an effort to cure certain cancers.

The birth of a Belgian company, a joint spin-off of the Ludwig Institute for Cancer Research (LICR) and the de Duve Institute of the Université catholique de Louvain (UCL), focusing on new drug discovery, has been made [...]

« Previous
Newer »